Facial Injectables Market

According to Stratistics MRC, the Global Facial Injectables Market is accounted for $5.94 billion in 2023 and is expected to reach $12.80 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Dermal fillers, also referred to as facial injectable products, are cosmetics that rejuvenate the face. In order to improve aesthetic beauty, these facial injectable products are typically used to treat wrinkles and other early signs of aging. It is also aided in the number of elderly people and the development of superior facial injectables like artificial calcium hydroxylapatite fillers.

According to the American Society of Plastic Surgeons (ASPS), in 2019, an estimated 25.0% of cosmetic procedures were performed in hospitals in the United States.



Market Dynamics:

Driver:

Increasing demand for minimally invasive cosmetic procedures

The global Facial Injectables market expected to drive growth during the forecast period, due to the desire for minimal recovery time, less pain, and fewer risks associated with surgery, the demand for non-invasive cosmetic procedures is increasing quickly. People who want to enhance their appearance without having surgery have a convenient, non-invasive option with facial injectables. Social media and the selfie culture that has developed as a result of people's increasing desire to present their best selves to the world have also contributed to this trend.

Restraint:

Very expensive

The global Facial Injectables market expected to hinder growth during the forecast period. Particularly in developing nations, where the cost of treatment can be prohibitive for many people, the high cost of facial injectables can be a major barrier to patient uptake. Additionally, the high price of these treatments may deter patients from getting maintenance injections, resulting in lower overall market revenue for businesses. In an effort to resolve this problem, some businesses are looking into different pricing structures, like subscription-based plans, which might make facial injectables more affordable for a wider range of patients.

Opportunity:

Rising interest in combination therapies

The global Facial Injectables market expected to drive growth during the forecast period. Combination therapies, which mix various facial injectables, including fillers and neuromodulators, are gaining popularity. Businesses that can provide comprehensive treatment options that incorporate multiple therapies will probably be well-positioned to benefit from this trend. As an illustration, some businesses now provide "liquid facelift" treatments that combine injectables with other minimally invasive techniques to offer a complete facial rejuvenation solution.

Threat:

Disruptions in the supply chain

The global Facial Injectables market expected to hamper growth during the forecast period. A disruption in the facial injectables market could result from a lack of raw materials or manufacturing equipment, for example. These setbacks may result in slower product development and manufacturing, a smaller supply, and higher consumer prices. Companies in the market need to diversify their supply chains, make investments in inventory management systems, and keep strong ties with suppliers to guarantee a steady supply of raw materials to combat this threat.

Covid-19 Impact:

Due to safety concerns, financial uncertainty, disruption of supply chains, and increased regulatory scrutiny, the COVID-19 pandemic has had an impact on the facial injectables market, resulting in decreased demand. To adapt, businesses have made investments in new technologies, safety procedures, and product development. As businesses navigate the challenges of the pandemic, the market is likely to remain dynamic and innovative. The facial injectables market is likely to stay dynamic and innovative as the world struggles to deal with the pandemic's challenges because businesses are working hard to meet patients' changing needs in an environment that is changing quickly.

The dermal fillers segment is expected to be the largest during the forecast period

The dermal fillers segment is expected to be the largest share during the forecast period Dermal fillers are popular for their efficiency, affordability, and comparably low risk of complications when compared to surgical procedures. They are used to restore volume and smooth out wrinkles. The proliferation of this market has been aided by the accessibility of a wide variety of dermal filler products with various formulations and injection methods. The aging population, rising awareness and acceptance of non-surgical cosmetic procedures, and ongoing product innovation will all contribute to this growth. Companies in the market are likely to invest in R&D to develop new and improved products that offer better results, longer-lasting effects, and fewer side effects as the demand for dermal fillers rises.

The ambulatory surgery centers segment is expected to have the highest CAGR during the forecast period

The ambulatory surgery centers segment is anticipated to witness the fastest CAGR growth during the forecast period Patients looking to enhance their appearance can choose from a variety of surgical and non-surgical procedures at ambulatory surgery centers (ASCs), including facial injectables. Some of the factors influencing the growth of this market include the rising demand for minimally invasive cosmetic procedures, the growing knowledge of the advantages of facial injectables, and the increasing acceptance of ASCs. In order to offer their patients safe and effective cosmetic services, many ASCs have also made investments in new technologies, equipment, and staff training.

Region with largest share:

The North America region market is estimated to witness a largest share of the global Facial Injectables market during the forecast period, due to the high demand for non-invasive aesthetic procedures, the United States is North America's largest market for facial injectables. The market in this region has expanded as a result of rising awareness and acceptance of cosmetic procedures as well as the availability of a wide variety of facial injectable products. The market for facial injectables in North America is anticipated to expand over the ensuing years, helped along by the rising acceptance of minimally invasive cosmetic procedures and ongoing developments in technology.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The demand for non-surgical cosmetic procedures is rising, there is more disposable income available, and people are becoming more aware of and accepting of aesthetic procedures, all of which contribute to this region's growth. The availability of cutting-edge and novel facial injectable products, as well as the rising number of healthcare facilities and medical professionals providing these services, are anticipated to support growth in this area. Additionally, the market for facial injectables in Asia Pacific is anticipated to expand as a result of the expanding trend of medical tourism in nations like Thailand, South Korea, and India.



Key players in the market

Some of the key players in Facial Injectables market include Allergan, Plc., Alma Laser , Anika Therapeutics, Inc., Antares Pharma , Bausch Health Companies In, BIOPLUS CO., LTD., Bioxis Pharmaceuticals, Bloomage BioTechnology Corporation Limited , ColBar LifeScience Ltd., Dickinson and Company, Galderma Pharma S.A., Ipsen Pharma, Medytox, Inc., Merz Pharma, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., Sinclair Pharma Plc, Solta Medical, Suneva Medical, Inc. and Syneron Candela.

Key Developments:

In August 2022, Allergan Healthcare India launched Juvéderm VOLUX, an injectable implant intended to restore and create the volume of the face, under its Business Unit of Allergan Aesthetics.

In March 2022, Galderma presented its new clinical data and high patient satisfaction across its portfolio of dermal fillers, collagen bio stimulators, and liquid neuromodulators at AMWC 2022. Galderma presented a range of new scientific data on its portfolio on its hyaluronic acid dermal filler range, its first liquid neuromodulator, and its original collagen biostimulator at the Aesthetic & Anti-Aging Medicine World Congress 2022.

In February 2022, Amneal expanded its injectables portfolio with 4 new products. Dexamethasone sodium phosphate injection, USP 10 mg/mL, azacitidine 100 mg, carboprost tromethamine injection, USP 250 mcg/mL, and atropine sulfate injection, USP 0.5 mg/5 mL, have received Abbreviated New Drug Application approval from the US Food and Drug Administration. Dexamethasone and azacitidine are both currently on the FDA drug shortage list, and Atroprine was granted Competitive Generic Therapy status by the FDA.

Product Types Covered:
• Wrinkle Relaxers
• Dermal Fillers
• Polymer Fillers
• Other Product Types

Applications Covered:
• Wrinkle Reduction
• Facelift
• Aesthetics
• Therapeutics
• Acne Scar Treatment
• Lipoatrophy Treatment
• Facial Line Correction
• Lip Augmentation
• Other Applications

End Users Covered:
• Hospitals
• Ambulatory Surgery Centers
• Dermatology Clinics
• Cosmetic Centers
• Dermatology Research Institutes
• Beauty Clinics
• Medical Spas
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances